17 April 2021 — Sebastian Rushworth M.D.
by Sebastian Rushworth, M.D.
Poor Astra-Zeneca. The covid-19 vaccine that they had hoped would generate an endless tide of goodwill is instead turning in to one long public relations disaster. First it was the case of transverse myelitis that caused them to have to halt their vaccine trial temporarily. Then it turned out that they had given the wrong dose of vaccine to a bunch of participants in the trial. Then, when the preliminary trial data was published, the vaccine only appeared to be 70% effective at preventing covid-19, while vaccines by competitors Pfizer and Moderna were more than 90% effective. And now, perhaps worst of all, it appears that their vaccine has killed several previously healthy young healthcare workers. Poor poor Astra-Zeneca.